Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fredrik Hieronymus

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
The Lancet. Psychiatry|June 11, 2019
Which antidepressant doses are optimal?Fredrik Hieronymus
The American Journal of Psychiatry|August 2, 2016
Inclusion of Flexible-Dose Trials in the Meta-Analysis of SSRI Dose-DependencyFredrik Hieronymus, Elias Eriksson
Psychological Medicine|September 25, 2024
Letter to the editor regarding 'Is combined antidepressant medication (ADM) and psychotherapy better than either monotherapy at preventing suicide attempts and other psychiatric serious adverse events for depressed patients? A rare events meta-analysis'Alexander Lisinski, Fredrik Hieronymus
The New England Journal of Medicine|August 26, 2021
Psilocybin for DepressionFredrik Hieronymus, Søren D Østergaard
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 21, 2021
Rating, berating or overrating antidepressant efficacy? The case of the Hamilton depression rating scaleFredrik Hieronymus, Søren D Østergaard
The New England Journal of Medicine|February 22, 2023
Psilocybin for Treatment-Resistant DepressionSøren D Østergaard, Fredrik Hieronymus
Eclinicalmedicine|November 21, 2024
Impact of sedative and appetite-increasing properties on the apparent antidepressant efficacy of mirtazapine, selective serotonin reuptake inhibitors and amitriptyline: an item-based, patient-level meta-analysisFredrik Hieronymus, Alexander Lisinski, Elias Eriksson
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|January 11, 2022
Clinical response to SSRIs relative to cognitive behavioral therapy in depression: a symptom-specific approachLynn Boschloo, Fredrik Hieronymus, Pim Cuijpers, et al.
Acta Psychiatrica Scandinavica|July 12, 2024
A target trial emulation comparing the antidepressant effectiveness of selective serotonin reuptake inhibitors (SSRIs) highlighting the importance of patent-related confounding by indicationChristopher Rohde, Fredrik Hieronymus, Søren Dinesen Østergaard
The Lancet. Psychiatry|October 22, 2019
How do we determine whether antidepressants are useful or not? - Authors' replyFredrik Hieronymus, Alexander Lisinski, Staffan Nilsson, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
The Lancet. Psychiatry|June 11, 2019
Which antidepressant doses are optimal?Fredrik Hieronymus
The American Journal of Psychiatry|August 2, 2016
Inclusion of Flexible-Dose Trials in the Meta-Analysis of SSRI Dose-DependencyFredrik Hieronymus, Elias Eriksson
Psychological Medicine|September 25, 2024
Letter to the editor regarding 'Is combined antidepressant medication (ADM) and psychotherapy better than either monotherapy at preventing suicide attempts and other psychiatric serious adverse events for depressed patients? A rare events meta-analysis'Alexander Lisinski, Fredrik Hieronymus
The New England Journal of Medicine|August 26, 2021
Psilocybin for DepressionFredrik Hieronymus, Søren D Østergaard
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 21, 2021
Rating, berating or overrating antidepressant efficacy? The case of the Hamilton depression rating scaleFredrik Hieronymus, Søren D Østergaard
The New England Journal of Medicine|February 22, 2023
Psilocybin for Treatment-Resistant DepressionSøren D Østergaard, Fredrik Hieronymus
Eclinicalmedicine|November 21, 2024
Impact of sedative and appetite-increasing properties on the apparent antidepressant efficacy of mirtazapine, selective serotonin reuptake inhibitors and amitriptyline: an item-based, patient-level meta-analysisFredrik Hieronymus, Alexander Lisinski, Elias Eriksson
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|January 11, 2022
Clinical response to SSRIs relative to cognitive behavioral therapy in depression: a symptom-specific approachLynn Boschloo, Fredrik Hieronymus, Pim Cuijpers, et al.
Acta Psychiatrica Scandinavica|July 12, 2024
A target trial emulation comparing the antidepressant effectiveness of selective serotonin reuptake inhibitors (SSRIs) highlighting the importance of patent-related confounding by indicationChristopher Rohde, Fredrik Hieronymus, Søren Dinesen Østergaard
The Lancet. Psychiatry|October 22, 2019
How do we determine whether antidepressants are useful or not? - Authors' replyFredrik Hieronymus, Alexander Lisinski, Staffan Nilsson, et al.
Pageof 4